Clinical Trial Update: BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Biodentine versus formocresol pulpotomy in primary molars has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries

Drugs mentioned

• Biodentine (tricalcium silicate cement)
• Formocresol (Formocresol)

Snippet

Sponsor: King Abdulaziz University | Conditions: Dental Caries, Pulpotomy | Phase 4 | Status: COMPLETED